Processa Pharmaceuticals, Inc. PCSA Q3 2025 earnings
Reported November 6, 2025 · Before market open
EPS-$1.75Beat by $0.25
EPS estimate-$2.00
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$1.00
Versus estimates
Diluted EPS
Ask the moment Processa Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Processa Pharmaceuticals, Inc. report Q3 2025 earnings?
- Processa Pharmaceuticals, Inc. (PCSA) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Processa Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Processa Pharmaceuticals, Inc. reported eps of $-1.75 for Q3 2025.
- Did Processa Pharmaceuticals, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-2.00 by $0.25.
- How did Processa Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 69.9% from $-1.03.
- Where can I find Processa Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001493152-25-021069) directly on SEC EDGAR. The filing index links above go to sec.gov.